Citadel Advisors’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q2
Hold
0
4407
2015
Q1
Sell
-11,940
Closed -$1.11M 4311
2014
Q4
$1.11M Buy
11,940
+292
+3% +$27.1K ﹤0.01% 2053
2014
Q3
$801K Sell
11,648
-4,428
-28% -$305K ﹤0.01% 2133
2014
Q2
$1.69M Sell
16,076
-15,051
-48% -$1.58M ﹤0.01% 1578
2014
Q1
$2.58M Buy
31,127
+26,077
+516% +$2.16M ﹤0.01% 1348
2013
Q4
$327K Buy
+5,050
New +$327K ﹤0.01% 2258